April Kaye Bullock Anthony
CIK 1629441 · View on SEC EDGAR ↗
First SEC filing: April 29, 2015 · Latest: Jan. 12, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 25, 2023 | FFIN | P | 5,000 | $22.90 | $114,500 | 93,146 Direct | +5.67% | Acquired | 50.0% (price as of 2026-08-21) |
| Oct. 25, 2022 | FFIN | P | 5,000 | $36.80 | $184,000 | 85,627 Direct | +6.20% | Acquired | -6.6% (price as of 2026-08-21) |
| May 6, 2022 | FFIN | P | 5,000 | $40.85 | $204,250 | 80,627 Direct | +6.61% | Acquired | -15.9% (price as of 2026-08-21) |
| May 5, 2022 | FFIN | P | 5,000 | $41.00 | $205,000 | 75,627 Direct | +7.08% | Acquired | -16.2% (price as of 2026-08-21) |
| May 3, 2022 | FFIN | P | 5,000 | $41.00 | $205,000 | 70,627 Direct | +7.62% | Acquired | -16.2% (price as of 2026-08-21) |
| May 14, 2020 | FFIN | P | 2,500 | $24.50 | $61,250 | 62,935 Direct | +4.14% | Acquired | 40.3% (price as of 2026-08-21) |
| May 14, 2020 | FFIN | P | 2,500 | $24.25 | $60,625 | 60,435 Direct | +4.32% | Acquired | 41.7% (price as of 2026-08-21) |
| May 13, 2020 | FFIN | P | 5,000 | $24.75 | $123,750 | 57,935 Direct | +9.45% | Acquired | 38.8% (price as of 2026-08-21) |
| May 13, 2020 | FFIN | P | 5,000 | $25.10 | $125,500 | 52,935 Direct | +10.43% | Acquired | 36.9% (price as of 2026-08-21) |
| May 12, 2020 | FFIN | P | 5,000 | $26.00 | $130,000 | 47,935 Direct | +11.65% | Acquired | 32.2% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 8,083 | $60.76 | $491,123 | 191,740 Direct | +4.40% | Acquired | 150.4% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 20,580 | $59.95 | $1,233,771 | 183,657 Direct | +12.62% | Acquired | 153.7% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 41,607 | $58.91 | $2,451,068 | 163,077 Direct | +34.25% | Acquired | 158.2% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 38,882 | $58.09 | $2,258,655 | 121,470 Direct | +47.08% | Acquired | 161.9% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 10,738 | $57.29 | $615,180 | 82,588 Direct | +14.95% | Acquired | 165.5% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 4,410 | $56.44 | $248,900 | 71,850 Direct | +6.54% | Acquired | 169.5% (price as of 2026-08-21) |
| March 12, 2020 | EHC | P | 700 | $54.50 | $38,150 | 67,440 Direct | +1.05% | Acquired | 179.1% (price as of 2026-08-21) |
| March 12, 2020 | FFIN | P | 549 | $21.02 | $11,540 | 40,779 Direct | +1.36% | Acquired | 63.5% (price as of 2026-08-21) |
| March 12, 2020 | FFIN | P | 10,000 | $21.32 | $213,200 | 40,230 Direct | +33.08% | Acquired | 61.2% (price as of 2026-08-21) |
| March 11, 2020 | EHC | P | 40,000 | $64.24 | $2,569,600 | 66,740 Direct | +149.59% | Acquired | 136.8% (price as of 2026-08-21) |
| March 9, 2020 | FFIN | P | 20,000 | $24.00 | $480,000 | 30,230 Direct | +195.50% | Acquired | 43.2% (price as of 2026-08-21) |
| March 9, 2020 | FFIN | P | 28,256 | $24.00 | $678,144 | 38,486 Direct | +276.21% | Acquired | 43.2% (price as of 2026-08-21) |
| March 9, 2020 | FFIN | P | 7,036 | $24.00 | $168,864 | 14,072 Indirect | +100.00% | Acquired | 43.2% (price as of 2026-08-21) |
| March 9, 2020 | FFIN | P | 12,000 | $24.00 | $288,000 | 24,000 Indirect | +100.00% | Acquired | 43.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 5, 2021 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (3,240) | $76.54 | March 2, 2030 | 3,240 | Disposed |
| May 5, 2021 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (4,343) | $63.77 | March 1, 2029 | 4,343 | Disposed |
| March 2, 2021 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (9,375) | $80.40 | March 2, 2031 | 9,375 | Acquired |
| March 2, 2020 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (9,718) | $76.54 | March 2, 2030 | 9,718 | Acquired |
| March 1, 2019 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock (6,515) | $63.77 | March 1, 2029 | 6,515 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $550,000 | — | $735,343 | $180,108 | — | — | $1,983 | $1,467,434 |
| 2020 | $524,615 | — | $683,514 | $150,473 | $371,250 | — | $3,762 | $1,733,614 |
| 2019 | $347,006 | — | $1,908,293 | $100,656 | $173,503 | — | $2,898 | $2,532,356 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.